ACS SYMPOSIUM SERIES 583
Taxane Anticancer Agents Taxane Anticancer Agents Downloaded from pubs.acs.org by 80.82.77.83 on 08/22/17. For personal use only.
Basic Science and Current Status Gunda I. Georg, EDITOR University of Kansas
Thomas T. Chen, EDITOR University of Tennessee
Iwao Ojima, EDITOR State University of New York at Stony Brook
Dolatrai M . Vyas, EDITOR Bristol-Myers Squibb PRI Developed from symposia sponsored by the Divisions of Chemical Health and Safety, Medicinal Chemistry, and Organic Chemistry at the 207th National Meeting of the American Chemical Society, San Diego, California, March 13-17, 1994
American Chemical Society, Washington, DC 1995
Library of Congress Cataloging-in-Publication Data Taxane anticancer agents: basic science and current status: developed from symposia sponsored by the Divisions of Chemical Health and Safety, Medicinal Chemistry, and Organic Chemistry at the 207th National Meeting of the American Chemical Society, San Diego, California, March 13-17, 1994 / Gunda I. Georg, editor ... [et al.].
Taxane Anticancer Agents Downloaded from pubs.acs.org by 80.82.77.83 on 08/22/17. For personal use only.
p.
cm.—(ACS symposium series, ISSN 0097-6156; 583)
Includes bibliographical references and indexes. ISBN 0-8412-3073-0 1. Taxol—Congresses. I. Georg, Gunda I. II. American Chemical Society. Division of Chemical Health and Safety. III. American Chemical Society. Division of Medicinal Chemistry. IV. American Chemical Society. Division of Organic Chemistry. V . American Chemical Society. Meeting (207th: 1994: San Diego, Calif.) VI. Series. [DNLM: 1. Taxol—chemistry—congresses. ogy—congresses. Q V 269 T235 1994]
2. Taxol—pharmacol-
RC271.T38T38 1994 616.99'4061—dc20 DNLM/DLC for Library of Congress
94-37226 CIP
The paper used in this publication meets the minimum requirements of American National Standard for Information Sciences—Permanence of Paper for Printed Library Materials, ANSI Z39.48-1984. © Copyright © 1995 American Chemical Society A l l Rights Reserved. The appearance of the code at the bottom of the first page of each chapter in this volume indicates the copyright owner's consent that reprographic copies of the chapter may be made for personal or internal use or for the personal or internal use of specific clients. This consent is given on the condition, however, that the copier pay the stated per-copy fee through the Copyright Clearance Center, Inc., 27 Congress Street, Salem, MA 01970, for copying beyond that permitted by Sections 107 or 108 of the U.S. Copyright Law. This consent does not extend to copying or transmission by any means—graphic or electronic—for any other purpose, such as for general distribution, for advertising or promotional purposes, for creating a new collective work, for resale, or for information storage and retrieval systems. The copying fee for each chapter is indicated in the code at the bottom of the first page of the chapter. The citation of trade names and/or names of manufacturers in this publication is not to be construed as an endorsement or as approval by A C S of the commercial products or services referenced herein; nor should the mere reference herein to any drawing, specification, chemical process, or other data be regarded as a license or as a conveyance of any right or permission to the holder, reader, or any other person or corporation, to manufacture, reproduce, use, or sell any patented invention or copyrighted work that may in any way be related thereto. Registered names, trademarks, etc., used in this publication, even without specific indication thereof, are not to be considered unprotected by law. PRINTED IN THE U N I T E D STATES O F A M E R I C A
1994 Advisory Board ACS Symposium Series
Taxane Anticancer Agents Downloaded from pubs.acs.org by 80.82.77.83 on 08/22/17. For personal use only.
M . Joan Comstock, Series Editor Robert J. Alaimo
Douglas R. Lloyd
Procter & Gamble Pharmaceuticals
The University of Texas at Austin
Mark Arnold
Cynthia A. Maryanoff
University of Iowa
R. W. Johnson Pharmaceutical Research Institute
David Baker University of Tennessee
Julius J. Menn
Arindam Bose
Western Cotton Research Laboratory, U.S. Department of Agriculture
Pfizer Central Research
Roger A. Minear Robert F. Brady, Jr. Naval Research Laboratory
University of Illinois at Urbana-Champaign
Margaret A. Cavanaugh
Vincent Pecoraro
National Science Foundation
University of Michigan
Arthur B. Ellis
Marshall Phillips
University of Wisconsin at Madison
Delmont Laboratories
Dennis W. Hess
George W. Roberts
Lehigh University
North Carolina State University
Hiroshi Ito
A. Truman Schwartz
IBM Almaden Research Center
Macalaster College
Madeleine M . Joullie
John R. Shapley
University of Pennsylvania
University of Illinois at Urbana-Champaign
Lawrence P. Klemann Nabisco Foods Group
L. Somasundaram DuPont
Gretchen S. Kohl Dow-Corning Corporation
Michael D. Taylor Parke-Davis Pharmaceutical Research
Bonnie Lawlor Institute for Scientific Information
Peter Willett University of Sheffield (England)
Foreword
Taxane Anticancer Agents Downloaded from pubs.acs.org by 80.82.77.83 on 08/22/17. For personal use only.
JLHE A C S S Y M P O S I U M SERIES was first published in 1974 to
provide a mechanism for publishing symposia quickly in book form. The purpose of this series is to publish comprehensive books developed from symposia, which are usually "snapshots in time" of the current research being done on a topic, plus some review material on the topic. For this reason, it is necessary that the papers be published as quickly as possible. Before a symposium-based book is put under contract, the proposed table of contents is reviewed for appropriateness to the topic and for comprehensiveness of the collection. Some papers are excluded at this point, and others are added to round out the scope of the volume. In addition, a draft of each paper is peer-reviewed prior to final acceptance or rejection. This anonymous review process is supervised by the organizer^) of the symposium, who become the editor(s) of the book. The authors then revise their papers according to the recommendations of both the reviewers and the editors, prepare camera-ready copy, and submit the final papers to the editors, who check that all necessary revisions have been made. As a rule, only original research papers and original review papers are included in the volumes. Verbatim reproductions of previously published papers are not accepted. M. Joan Comstock Series Editor
